Characteristic of Intestinal Flora in Male Elderly With Small Intestinal Bacterial Overgrowth (IFOSIBO)
Study on Clinical Features, Intestinal Flora and Standardized Treatment in Male Elderly With Small Intestinal Bacterial Overgrowth
Sponsor: Chinese PLA General Hospital
This observational or N/A phase trial investigates 16s rRNA and Elderly and is currently ongoing. Chinese PLA General Hospital leads this study, which shows 7 recorded versions since 2018 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Dec 2021 — Jul 2024 [monthly]
Unknown Status
-
Jan 2021 — Dec 2021 [monthly]
Unknown Status
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
▶ Show 2 earlier versions
-
Oct 2020 — Nov 2020 [monthly]
Unknown Status
Status: Enrolling By Invitation → Unknown Status
-
Oct 2018 — Oct 2020 [monthly]
Enrolling By Invitation
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Chinese PLA General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .